GRTS gritstonebio.com: Enterprise Value to EBITDA Ratio

Graphic logo of Gritstone bio (GRTS)

The EV/EBITDA price chart for Gritstone bio, Inc. (GRTS) on the GURU.Markets platform is . Gritstone bio, Inc. develops unique AI-driven vaccines, which guarantees the company pricing power when setting service costs. Despite the challenges of scaling personalized treatments and significant development expenses, the business relies on high margins. Current quotes already price in R&D costs and the anticipation of clinical trial results.

Gritstone bio Inc. - GRTS Total Company Value to Operating Income Before Depreciation Ratio (period 07/04/2022 - 11/14/2026)

Summary analytical data breakdowns for gritstonebio.com (GRTS)

- stock price and consensus target price:
Stock Quotes Gritstone bio|GRTS - Average Forecast Price
- company stock capitalization data:
Market Valuation Gritstone bio, Inc.|GRTS - Value Adjusted for Debt and Cash
- business book valuation details:
Book Value per Share Gritstone bio|GRTS - Book Valuation of Business|Market Value to Book Value Ratio gritstonebio.com|GRTS - Cumulative Company Assets
- debt and solvency information:
Debt to Equity Gritstone bio, Inc.|GRTS - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Gritstone bio|GRTS - Company Aggregate Debts|Debt to Book Capitalization Ratio Gritstone bio, Inc.|GRTS - Company Long-Term Indebtedness|Company Short-Term Debt Gritstone bio|Quick Liquidity Indicator gritstonebio.com
- financial results and valuation multiples details:
GRTS - Annual Net Income|Future Profit Gritstone bio, Inc.|GRTS - Market Price to Net Income Ratio|Forward P/E Multiple Gritstone bio|GRTS - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Gritstone bio, Inc.|GRTS - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Gritstone bio|GRTS - Earnings per share for the trailing year|Quarterly EPS earnings growth gritstonebio.com|GRTS - Earnings growth in current year|Net earnings per share growth forecast for next year Gritstone bio, Inc.
- sales volume and revenue indicators:
GRTS - Company Annual Revenue|Company Future Sales Volume Gritstone bio|GRTS - Price to Sales|Forward P/S Multiple Gritstone bio, Inc.
Fundamental company analysis:GRTS (Gritstone Bio)
Original product of Gritstone bio Inc.

This indicator correlates the total enterprise value, including net debt, with its operating profit before taxes and depreciation. The EV/EBITDA ratio dynamics for Gritstone bio, Inc. (GRTS), accounting for debt load, determine the extent of asset overvaluation relative to generated cash flow. Reducing Gritstone bio, Inc. (GRTS) dependence on external manufacturing through its own plant optimizes the cost structure, directly impacting the denominator of this multiple.

Competitor analysis for Gritstone bio, Inc.

ImmunityBio Corp - Enterprise Value to EBITDA Ratio|Immunocore Corp (IMCR) - Company Value to EBITDA|JANX: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation RCUS (arcusbio.com)|ZYME: EV/EBITDA Multiple|TNGX - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Iovance|Enterprise Value to EBITDA Ratio Immatics Biotechnologies (IMTX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Xencor, Inc. (XNCR)|Enterprise Value to EBITDA Ratio compasstherapeutics.com CMPX|Replimune - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Lyell LYEL|IPHA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|PYXS (Pyxis Oncology, Inc.) - Enterprise Value to Operating Income Before Depreciation|cgen.com (CGEN) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA iobiotech.com (IOBT)|Enterprise Value to EBITDA Ratio STRO|INKT - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio HOWL (Werewolf Therapeutics)|Enterprise Value to Operating Income Before Depreciation Ratio IMMX|EV/EBITDA Multiple ALXO (ALX Oncology)|Business Value to Operating Income Before Depreciation CUE|PDS Biotechnology Corp - EV/EBITDA Multiple|Company Value to EBITDA Sonnet BioTherapeutics|MAIA Biotechnology Inc (MAIA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Liminatus - Business Value to Operating Income Before Depreciation|LVTX (LAVA Therapeutics NV) - EV/EBITDA Multiple|EV/EBITDA Multiple nextcure.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Leap Therapeutics, Inc. (LPTX)|INTS: Company Value to Operating Income Before Depreciation Ratio|Sensei Biotherapeutics, Inc. - Enterprise Value to EBITDA Ratio|Theriva Corp (TOVX) - Company Value to EBITDA|Kineta, Inc. - EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple neximmune.com (NEXI)|turnstonebio.com (TSBX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Vaccinex Inc. - Business Value to Operating Income Before Depreciation|HARP (Harpoon Tx) - EV/EBITDA Multiple